Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Rani Therapeutics Holdings (RANI) Shares Outstanding (2020 - 2026)

Rani Therapeutics Holdings' Shares Outstanding history spans 7 years, with the latest figure at $24.0 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding fell 28.6% to $24.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $24.0 million, a 28.6% decrease, with the full-year FY2025 number at $24.0 million, down 28.3% from a year prior.
  • Shares Outstanding came in at $99.8 million for Q1 2026, up from $97.6 million in the prior quarter.
  • The five-year high for Shares Outstanding was $99.8 million in Q1 2026, with the low at $24.0 million in Q2 2025.
  • Historically, Shares Outstanding has averaged $34.1 million across 5 years, with a median of $25.3 million in 2022.
  • Peak annual rise in Shares Outstanding hit 2449300.0% in 2022, while the deepest fall reached 47.17% in 2022.
  • Year by year, Shares Outstanding stood at $24.1 million in 2022, then rose by 7.96% to $26.0 million in 2023, then increased by 28.4% to $33.4 million in 2024, then fell by 28.3% to $24.0 million in 2025, then changed by 0.0% to $24.0 million in 2026.
  • Business Quant data shows Shares Outstanding for RANI at $24.0 million in Q1 2026, $24.0 million in Q4 2025, and $47.9 million in Q3 2025.